XML 52 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net loss $ (6,863,000) $ (6,959,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Common stock issued for services 11,000 176,000
Share based compensation 560,000 170,000
Depreciation and amortization 185,000 267,000
Abandonment and impairment of capitalized patent costs 733,000 35,000
Change in operating assets and liabilities:    
Contract assets (14,000) 145,000
Prepaid expenses and other assets (35,000) (210,000)
Accounts payable and accrued liabilities (270,000) 10,000
Accrued compensation and taxes 236,000 43,000
Net cash used in operating activities (5,457,000) (6,323,000)
Cash flows from investing activities:    
Acquisition of fixed assets (13,000) (44,000)
Disbursements for patents and other intangible assets (326,000) (313,000)
Maturity of short term treasury bills 4,924,000 0
Net cash provided by (used in) investing activities 4,585,000 (357,000)
Cash flows from financing activities:    
Proceeds from issuance of common stock, net of offering costs 0 23,511,000
Net cash provided by financing activities 0 23,511,000
Net increase (decrease) in cash and cash equivalents (872,000) 16,831,000
Cash and cash equivalents, beginning of year 8,949,000 1,247,000
Cash and cash equivalents, end of year $ 8,077,000 $ 18,078,000